IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
85.27
+0.52 (0.61%)
May 13, 2026, 4:00 PM EDT - Market closed
IRADIMED CORPORATION Revenue
IRADIMED CORPORATION had revenue of $21.98M in the quarter ending March 31, 2026, with 12.65% growth. This brings the company's revenue in the last twelve months to $86.28M, up 14.81% year-over-year. In the year 2025, IRADIMED CORPORATION had annual revenue of $83.81M with 14.43% growth.
Revenue (ttm)
$86.28M
Revenue Growth
+14.81%
P/S Ratio
12.63
Revenue / Employee
$519,771
Employees
166
Market Cap
1.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 83.81M | 10.57M | 14.43% |
| Dec 31, 2024 | 73.24M | 7.68M | 11.71% |
| Dec 31, 2023 | 65.56M | 12.26M | 23.00% |
| Dec 31, 2022 | 53.30M | 11.49M | 27.47% |
| Dec 31, 2021 | 41.81M | 10.10M | 31.83% |
| Dec 31, 2020 | 31.72M | -6.80M | -17.65% |
| Dec 31, 2019 | 38.52M | 8.08M | 26.54% |
| Dec 31, 2018 | 30.44M | 7.36M | 31.88% |
| Dec 31, 2017 | 23.08M | -9.41M | -28.97% |
| Dec 31, 2016 | 32.50M | 902.80K | 2.86% |
| Dec 31, 2015 | 31.59M | 15.94M | 101.84% |
| Dec 31, 2014 | 15.65M | 4.31M | 38.03% |
| Dec 31, 2013 | 11.34M | 3.66M | 47.56% |
| Dec 31, 2012 | 7.69M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Integra LifeSciences Holdings | 1.64B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.03B |
| Lumexa Imaging Holdings | 1.02B |
| Inspire Medical Systems | 915.25M |
| Alphatec Holdings | 787.08M |
| Avanos Medical | 715.90M |
| Bioventus | 576.30M |
IRMD News
- 12 days ago - IRADIMED CORPORATION Earnings Call Transcript: Q1 2026 - Transcripts
- 13 days ago - IRADIMED CORPORATION Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 17 days ago - IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026 - GlobeNewsWire
- 4 weeks ago - IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - iRadimed initiated with a Buy at Freedom Broker - TheFly
- 2 months ago - IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference - GlobeNewsWire
- 3 months ago - iRadimed price target raised to $120 from $100 at Lake Street - TheFly
- 3 months ago - iRadimed price target raised to $120 from $98 at Roth Capital - TheFly